Secretary of War Pete Hegseth announced Wednesday that the Pentagon will begin screening service members over 30 for testosterone deficiency as part of its annual health assessment, with optional screening available to those under 30. If treatment is recommended, service members may choose to undergo testosterone replacement therapy.
The announcement drew immediate criticism from Democratic lawmakers who compared the initiative to cross-sex gender-affirming care, prompting a heated online response and raising questions about the intersection of military health policy and partisan politics.
What the Right Is Saying
Conservatives and military advocates pushed back sharply on the comparison. Meaghan Mobbs, a former Army paratrooper and president of the nonprofit R.T. Weatherman Foundation, posted: "If you are one of the people melting down because the Department of War wants to screen men over 30 for testosterone deficiency, I am begging you to spend ten minutes reading the science before letting Hegseth Derangement Syndrome rob you of common sense."
Mobbs explained the medical basis for the initiative. "Testosterone is not some cosmetic 'masculinity' metric," she wrote. "It is a major endocrine signal tied to muscle mass, bone density, red blood cell production, metabolism, sexual function, energy, concentration, mood, recovery, and physical performance." She noted that clinically low testosterone can present as exhaustion, loss of strength and muscle, impaired concentration, irritability, depressed mood, reduced motivation, and diminished sexual function.
Assistant Secretary of Health and Human Services Adm. Brian Christine wrote: "I fully support Secretary Hegseth's initiative at the Department of War in recognizing the importance of healthy testosterone levels in its warfighting men! Optimizing testosterone supports strength, endurance, healthy body composition, cognitive performance, mission readiness, and overall well-being—ensuring America's fighting force is prepared to perform at its highest level."
Hegseth clarified the program's intent. "This is not about artificial enhancement; it's about restoring and optimizing your natural capabilities, protecting your longevity and ensuring you have the biological foundation required to sustain the fight," he wrote in announcing what he labeled "the High-T Department of War."
What the Left Is Saying
Sen. Adam Schiff, D-Calif., wrote on X: "Pete Hegseth comes out in favor of gender-affirming care..." Sen. Mazie Hirono, D-Hawaii, posted: "So the Pentagon is promoting gender-affirming care now?" Both senators' posts drew significant engagement online.
Rep. Pramila Jayapal, D-Wash., raised the issue during a House hearing, calling the program "absurd." She suggested the government could begin testing whether representatives are "male enough to be in Congress."
"The Secretary of Forever Wars, Pete Hegseth, just announced they are going to provide hormone therapy to male service members who don't have enough testosterone," Jayapal wrote on X. "Let's be clear: This is gender-affirming care, and it completely debunks all of Republicans' attacks on trans people."
Sen. Tammy Duckworth, D-Ill., echoed the criticism: "Sounds like gender-affirming care to me." Critics of the Democrats' framing argued that providing testosterone supplementation to men with clinically low levels differs fundamentally from cross-sex hormone treatment.
What the Numbers Show
Testosterone levels naturally decline in men at a rate of approximately 1-2% per year after age 30, according to the Endocrine Society. Medical literature indicates that clinical testosterone deficiency affects an estimated 2-6% of adult men, with symptoms including fatigue, reduced muscle mass, decreased libido, and cognitive changes.
The Department of Defense has not yet released specific data on how many service members may be eligible for screening or treatment under the new program. Military health assessments are standard practice for readiness evaluation, though hormone-level screening has not previously been a routine component.
Online response to Democratic criticism was significant. Commenting on Schiff's post, one user wrote: "Giving testosterone to men is gender-affirming and not harmful. Chemically castrating a boy or a double mastectomy on a girl is gender-denying, irreversible and harmful." Another responded to Jayapal: "When a woman goes through menopause and gets hormone replacement she's not suddenly a trans person."
The Bottom Line
The debate over Hegseth's testosterone initiative reflects broader partisan conflicts over healthcare terminology and government authority. Democrats argue the comparison highlights what they characterize as Republican inconsistency on gender-related medical interventions, while Republicans contend the program addresses legitimate endocrine health concerns affecting military readiness.
The program's rollout remains in early stages. The Pentagon has not specified implementation timelines or budget allocations for expanded screening and potential treatment. Future congressional oversight hearings may probe whether the initiative falls within standard preventive healthcare or represents a departure from existing military health protocols.
What to watch: Whether Republican lawmakers publicly defend the initiative against Democratic criticism, how military medical associations respond, and whether the program faces any legal challenges regarding scope of care.